Iridina Due

Naphazoline Hydrochloride, the active ingredient in Iridina Due, is an alpha‑adrenergic agonist presented as an ophthalmic solution for ocular use. It reduces conjunctival redness and provides temporary relief of minor eye irritation in adults and children when appropriate. GNH USA supplies Iridina Due as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Iridina Due is an ocular decongestant that acts on the conjunctival vasculature to relieve redness and irritation. - Conjunctival hyperemia: reduces visible eye redness caused by dilated blood vessels. - Minor ocular irritation: alleviates discomfort and transient redness from environmental factors. - Eye redness due to mild allergic or irritant exposure: provides short‑term visual comfort.

Common Side Effects: - Burning sensation: mild, transient feeling after instillation. - Stinging: brief discomfort on the ocular surface. - Temporary blurred vision: resolves within minutes. - Mild itching: occasional sensation of irritation. - Dryness: slight reduction in tear film. - Redness rebound after prolonged use: may reappear if used excessively.

Serious or Rare Side Effects: - Severe ocular hypertension: marked increase in intra‑ocular pressure. - Corneal ulceration: rare but serious corneal damage. - Allergic reaction (angioedema): swelling of eyelids or surrounding tissue. - Irregular pupil dilation (mydriasis): abnormal pupil size. - Vision loss: extremely rare, requires immediate medical attention. - Systemic adrenergic effects: rapid heart rate or elevated blood pressure.

Before using Iridina Due, consider the following precautions. - Avoid prolonged use: may cause rebound redness and tachyphylaxis. - Do not use while wearing contact lenses: remove lenses before application. - Consult an eye specialist if you have glaucoma or ocular hypertension. - Avoid use in children under 2 years: safety not established. - Do not combine with other vasoconstrictive eye drops without professional advice. - Store at room temperature: keep in the original container, protect from light and moisture.

Iridina Due may interact with other ophthalmic or systemic agents. Major Interactions (Avoid): - Other ocular decongestants: additive vasoconstriction can increase risk of ischemia. - Monoamine oxidase inhibitors (MAOIs): potential systemic adrenergic stimulation. - Sympathomimetic agents: heightened cardiovascular effects. Moderate Interactions (Monitor Closely): - Topical anesthetics: may increase corneal toxicity when used together. - Antihistamine eye drops: monitor for increased irritation. - Systemic antihypertensives: observe blood pressure for possible fluctuations.